European Medicines Agency - Regulatory - Regulation of medicines

2 - Network organisation and process

    Description

Name

  

ECAPN - European Child & Adolescent Psychopharmacology Network
Existence of an identified contact person for external enquiries Yes Chairperson & Co-chairperson: Carmen Moreno, MD; Diane Purper-Ouakil, MD (Also principal investigators at each Centre)
Existence of an internal steering committee Yes Carmen Moreno, MD, Madrid, Spain Diane Purper Ouakil, MD , Montpellier , France, Veit Roessner, MD, Dresden, Germany Pieter Hoekstra, MD, Groningen, The Netherlands
Existence of an external advisory steering committee directing the reporting party Yes The current external steering comittee has just finished his term. We have now 10 candidates and the updated steering committee will be voted during the next Network Meeting that will be held October 2022
Existence of a website Yes https://www.ecnp.eu/research-innovation/networks-thematic-working-groups/List-ECNP-Networks/Child-and-adolescent-neuropsychopharmacology/ECAPN
Existence of newsletter No Minutes of meetings circulated by mail and there are project-specific newsletters Newsletter and websites only for specific studies not within the network: see: http://matrics-project.eu/images/MATRICS_NL_1.pdf https://www.aims-2-trials.eu/ https://conect4children.org/
Existence of internal databases for disease, condition treatment and/or outcome Yes ECNP, to which ECAPN belongs, has developed a database, in process of implementation for ECAPN
Provisions to ascertain data protection and data security Yes ECAPN Data Protection Guideline in the website
Procedures to access the database by third parties Yes Procedures for access by third parties are defined in individual studies but not at the network level.
Access to external databases/registries Yes Members of the network have extensive professional relationship with scientists and clinicians managing extensive clinical databases
Standardised process to access an external database No